| 1 |
Priester MI, Ten Hagen TLM. Image-guided drug delivery in nanosystem-based cancer therapies. Adv Drug Deliv Rev 2023;192:114621. [PMID: 36402247 DOI: 10.1016/j.addr.2022.114621] [Reference Citation Analysis]
|
| 2 |
Fahmy SA, Preis E, Dayyih AA, Alawak M, El-said Azzazy HM, Bakowsky U, Shoeib T. Thermosensitive Liposomes Encapsulating Nedaplatin and Picoplatin Demonstrate Enhanced Cytotoxicity against Breast Cancer Cells. ACS Omega 2022. [DOI: 10.1021/acsomega.2c04525] [Reference Citation Analysis]
|
| 3 |
Bhargava S, de la Puente-Secades S, Schurgers L, Jankowski J. Lipids and lipoproteins in cardiovascular diseases: a classification. Trends Endocrinol Metab 2022;33:409-23. [PMID: 35370062 DOI: 10.1016/j.tem.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Shimazoe K, Uenomachi M, Takahashi H. Imaging and sensing of pH and chemical state with nuclear-spin-correlated cascade gamma rays via radioactive tracer. Commun Phys 2022;5. [DOI: 10.1038/s42005-022-00801-w] [Reference Citation Analysis]
|
| 5 |
Saleemi MA, Lim V. Phytosomes Used for Herbal Drug Delivery. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-031-12658-1_9] [Reference Citation Analysis]
|
| 6 |
Detiger SE, Kremer TM, A S H Dalm V, de Keizer ROB, Wubbels RJ, Metselaar JM, van Hagen PM, Peeters RP, Paridaens D. A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure. Acta Ophthalmol 2021;99:797-804. [PMID: 33423386 DOI: 10.1111/aos.14751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Petroni D, Riccardi C, Cavasso D, Russo Krauss I, Paduano L, Montesarchio D, Menichetti L. Synthesis and Characterization of Multifunctional Nanovesicles Composed of POPC Lipid Molecules for Nuclear Imaging. Molecules 2021;26:6591. [PMID: 34770999 DOI: 10.3390/molecules26216591] [Reference Citation Analysis]
|
| 8 |
Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, Gangadharappa HV, Pardakhty A, Mehrbani M, Dell'Agli M, Nematollahi MH. Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature. Int J Nanomedicine 2021;16:6983-7022. [PMID: 34703224 DOI: 10.2147/IJN.S318416] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 9 |
Ruiz-Pulido G, Medina DI, Barani M, Rahdar A, Sargazi G, Baino F, Pandey S. Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review. Materials (Basel) 2021;14:3706. [PMID: 34279276 DOI: 10.3390/ma14133706] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Chang CH, Chang MC, Chang YJ, Chen LC, Lee TW, Ting G. Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. Int J Mol Sci 2021;22:3868. [PMID: 33918011 DOI: 10.3390/ijms22083868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Cabrera M, Lecot N, Fernández M, Gambini JP, Porcal W, Cabral P. 99mTc Stearyl 6-(benzylidenehydrazinyl) nicotinamide Liposomes as Tumor Permeability Evaluation Tracer. AAPS PharmSciTech 2021;22:115. [PMID: 33763814 DOI: 10.1208/s12249-021-01984-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Huang YS, Hsu WC, Lin CH, Lo SN, Cheng CN, Lin MS, Lee TW, Chang CH, Lan KL. Bi-Functional Radiotheranostics of 188Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells. Int J Mol Sci 2021;22:1902. [PMID: 33672989 DOI: 10.3390/ijms22041902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Kolašinac R, Bier D, Schmitt L, Yabluchanskiy A, Neumaier B, Merkel R, Csiszár A. Delivery of the Radionuclide (131)I Using Cationic Fusogenic Liposomes as Nanocarriers. Int J Mol Sci 2021;22. [PMID: 33466417 DOI: 10.3390/ijms22010457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 14 |
Cho E, Lu Y. Compartmentalizing Cell-Free Systems: Toward Creating Life-Like Artificial Cells and Beyond. ACS Synth Biol 2020;9:2881-901. [PMID: 33095011 DOI: 10.1021/acssynbio.0c00433] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 15 |
Aranda-Lara L, Morales-Avila E, Luna-Gutiérrez MA, Olivé-Alvarez E, Isaac-Olivé K. Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy. Chem Phys Lipids 2020;230:104934. [PMID: 32562666 DOI: 10.1016/j.chemphyslip.2020.104934] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 16 |
Datta P, Ray S. Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties. J Labelled Comp Radiopharm 2020. [PMID: 32220029 DOI: 10.1002/jlcr.3839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 17 |
Ghelfi M, Maddalena LA, Stuart JA, Atkinson J, Harroun TA, Marquardt D. Vitamin E-inspired multi-scale imaging agent. Bioorg Med Chem Lett 2019;29:107-14. [PMID: 30459096 DOI: 10.1016/j.bmcl.2018.10.052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Kamkaew A, Ehlerding EB, Cai W. Nanoparticles as Radiopharmaceutical Vectors. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_10] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Xia Y, Xu C, Zhang X, Ning P, Wang Z, Tian J, Chen X. Liposome-based probes for molecular imaging: from basic research to the bedside. Nanoscale 2019;11:5822-38. [DOI: 10.1039/c9nr00207c] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 20 |
Thakur A, Rodríguez-Rodríguez C, Saatchi K, Rose F, Esposito T, Nosrati Z, Andersen P, Christensen D, Häfeli UO, Foged C. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization. Front Immunol 2018;9:2825. [PMID: 30555488 DOI: 10.3389/fimmu.2018.02825] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 21 |
Wang D, Sun Y, Liu Y, Meng F, Lee RJ. Clinical translation of immunoliposomes for cancer therapy: recent perspectives. Expert Opin Drug Deliv 2018;15:893-903. [PMID: 30169978 DOI: 10.1080/17425247.2018.1517747] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 22 |
Wong P, Li L, Chea J, Delgado MK, Poku E, Szpikowska B, Bowles N, Minnix M, Colcher D, Wong JYC, Shively JE, Yazaki PJ. Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model. Cancer Biother Radiopharm 2017;32:247-57. [PMID: 28910151 DOI: 10.1089/cbr.2017.2253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Belfiore L, Saunders DN, Ranson M, Thurecht KJ, Storm G, Vine KL. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities. J Control Release 2018;277:1-13. [PMID: 29501721 DOI: 10.1016/j.jconrel.2018.02.040] [Cited by in Crossref: 154] [Cited by in F6Publishing: 135] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 24 |
Lamichhane N, Udayakumar TS, D'Souza WD, Simone CB 2nd, Raghavan SR, Polf J, Mahmood J. Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery. Molecules 2018;23:E288. [PMID: 29385755 DOI: 10.3390/molecules23020288] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 27.4] [Reference Citation Analysis]
|
| 25 |
Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric Nanoparticles. Radionanomedicine 2018. [DOI: 10.1007/978-3-319-67720-0_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 26 |
Jensen AI, Severin GW, Hansen AE, Fliedner FP, Eliasen R, Parhamifar L, Kjær A, Andresen TL, Henriksen JR. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of 52Mn-DOTA and 64Cu-DOTA using radiolabelled liposomes and PET imaging. Journal of Controlled Release 2018;269:100-9. [DOI: 10.1016/j.jconrel.2017.11.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 27 |
Brand C, Iacono P, Pérez-Medina C, Mulder WJM, Kircher MF, Reiner T. Specific Binding of Liposomal Nanoparticles through Inverse Electron-Demand Diels-Alder Click Chemistry. ChemistryOpen 2017;6:615-9. [PMID: 29046855 DOI: 10.1002/open.201700105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 28 |
Wong P, Li L, Chea J, Delgado MK, Crow D, Poku E, Szpikowska B, Bowles N, Channappa D, Colcher D, Wong JYC, Shively JE, Yazaki PJ. PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs. Nucl Med Biol 2017;47:62-8. [PMID: 28126683 DOI: 10.1016/j.nucmedbio.2017.01.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
